In May, Partners In Health announced a new partnership with UNITAID, Doctors Without Borders/ Médecins Sans Frontières (MSF), and IRD to revolutionize access to new multidrug-resistant tuberculosis (MDR-TB) treatment in 17 countries, especially among the poor.
“We’re grateful for this support from UNITAID, and particularly for their partnership, with which we’re hoping to make diagnosis and treatment of drug-resistant tuberculosis more effective and more tolerable for patients, as well as more readily accessible and lower-cost,” said Paul Farmer, MD, PhD, co-founder of Partners In Health and chief of BWH’s Division of Global Health Equity. “UNITAID has given us a way to use the power of markets to serve the poor, driving down the cost of essential commodities and helping to deliver them to the people who need them most.”
Read more about the UNITAID grant that will make this work possible.
Adapted from the BWH Global Health Hub blog.